The spectrum of conditions managed by Oral Medicine specialists is wide and includes,
amongst others, ulcerative and vesiculobullous diseases of the oral cavity, orofacial
neuropathies, salivary gland disorders, oral complications from cancer therapy, and
oral potentially malignant disorders, which may cause severe morbidity and mortality1. Due to the chronicity of many of these conditions, the primary management strategy
of most treatments are typically symptomatic in nature and not curative. The risk-benefit
balance for all treatments should be considered before commencement, and ideally be
accompanied by high-quality evidence base to support the decisions made by clinicians.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
November 1,
2022
Received:
November 1,
2022
Publication stage
In Press Journal Pre-ProofFootnotes
Note: This Editorial is part of the WWOM VIII projects
Funding: The WWOM VIII Steering Committee gratefully acknowledges the following organizations, companies, and individuals that provided financial support for WWOM VIII: American Academy of Oral Medicine, European Association of Oral Medicine, Church & Dwight Co. Inc., Colgate Palmolive, and patients of Dr. Ross Kerr.
Identification
Copyright
© 2023 Published by Elsevier Inc.
